A few mechanisms that don't reduce neatly to mesolimbic dopamine: (1) conditioned aversion, GLP-1 activation engages nausea/malaise circuits, so some of the reduction in substance use may reflect aversive conditioning rather than reward modulation per se
The wide inter-individual variability in disease pattern favours a switch-over trial design which, however, is foiled by the carry-over effect of todays high potency material eg
FDA Provided Clarity on GHK-Cu On May 14, 2026, the FDA restored non-injectable GHK-Cu to Category 1 of the 503A bulk drug substances list, confirming that the earlier withdrawal applied only to injectable routes of administration
There are simple, yet effective ways to get rid of the bloating and feel light again
PlexusDx sources compounded semaglutide and tirzepatide exclusively from licensed 503A compounding pharmacies, ensuring consistent fill accuracy and minimizing manufacturing-related air pockets